06 Dec Eylea As Good As Lucentis
The FDA approved Eylea as a new treatment for wet macular degeneration. Recent reports indicate the drug is similar to Lucentis after the initial year of treatment. Why is this bad news?...
The FDA approved Eylea as a new treatment for wet macular degeneration. Recent reports indicate the drug is similar to Lucentis after the initial year of treatment. Why is this bad news?...
VEGF Trap Eye is another anti-VEGF medication to be injected into the eye for the treatment of wet macular degeneration. The FDA did not approve recently, but will reconsider by November!...
VEGF-Trap (aka aflibercept), another anti-VEGF drug, moves closer to FDA approval as it received "priority review" status. This status means that the FDA process will be accelerated and the drug can be reviewed in 6 months versus the usual 10 month period....
VEGF Trap-Eye is a new injectable medication that blocks VEGF for the treatment of wet macular degeneration. It may be as good as Lucentis, but not given as often....
The American Academy of Ophthalmology is holding its annual meeting right now in San Francisco. Many "researchers" will be reporting the results of their research. Watch out for "too much information" over the internet!...